Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
PaperCitations, authors & open-access status
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 394 citations, 2016 year and closed oa status.
394
Citations
2016
Year
closed
OA Status